Quarterly report pursuant to Section 13 or 15(d)

STOCK-BASED COMPENSATION (Tables)

v3.24.1.1.u2
STOCK-BASED COMPENSATION (Tables)
3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
SCHEDULE OF STOCK BASED COMPENSATION

The following table summarizes stock-based compensation expense for the three months ended March 31, 2024 and 2023 (in thousands):

  

    2024     2023  
    For the three months ended March 31,  
    2024     2023  
             
Research and development   $ 346     $ 584  
General and administrative     1,220       186  
Total stock-based compensation expense   $ 1,546     $ 770  
SCHEDULE OF STOCK OPTION ACTIVITY

The following table summarizes stock option activity during the three months ended March 31, 2024:

 

   

Number of

Options

   

Weighted

Average

Exercise Price

   

Weighted

Average

Remaining

Contractual

Term (years)

   

Aggregate

Intrinsic Value

(in thousands)

 
                         
Outstanding at December 31, 2023     179,001     $ 38.58       6.83     $ 3  
Granted         $           $  
Cancelled/forfeited         $           $  
Exercised         $           $  
Outstanding at March 31, 2024     179,001     $ 38.58       6.58     $ 14  
Exercisable     143,907     $ 38.58       6.42     $ 6  
Unvested     35,094     $ 38.59       7.24     $ 8  
SCHEDULE OF RESTRICTED STOCK AWARD ACTIVITY

The following table summarizes restricted stock award activity during the three months ended March 31, 2024:

 

   

Number

of Awards

   

Weighted Average

Grant Date Fair

Value Per Unit

 
             
Outstanding at December 31, 2023     2,448,169     $ 4.25  
Granted     137,500     $ 5.31  
Cancelled/forfeited         $  
Vested     (43,050 )   $ 7.56  
Outstanding at March 31, 2024     2,542,619     $ 4.18